SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-054220
Filing Date
2019-10-15
Accepted
2019-10-15 17:29:38
Documents
57
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv531008_10q.htm 10-Q 419954
2 EXHIBIT 31.1 tv531008_ex31-1.htm EX-31.1 12341
3 EXHIBIT 32.1 tv531008_ex32-1.htm EX-32.1 5150
  Complete submission text file 0001104659-19-054220.txt   3727471

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20190831.xml EX-101.INS 810336
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20190831.xsd EX-101.SCH 38536
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20190831_cal.xml EX-101.CAL 26697
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20190831_def.xml EX-101.DEF 171417
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20190831_lab.xml EX-101.LAB 310684
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20190831_pre.xml EX-101.PRE 283572
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 191151662
SIC: 2834 Pharmaceutical Preparations